<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="53925">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02404142</url>
  </required_header>
  <id_info>
    <org_study_id>PI14034</org_study_id>
    <nct_id>NCT02404142</nct_id>
  </id_info>
  <brief_title>Curarisation and Intubation Conditions During Videolaryngoscopy With Glidescope Titanium</brief_title>
  <acronym>GICAC</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>CHU de Reims</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Verathon</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>CHU de Reims</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this prospective, randomized study, the investigators assess the intubation conditions
      during videolaryngoscopy with Glidescope Titanium whether patients receive (curare
      (Atracurium) group) or no (control group) within elective surgery patients with no difficult
      intubation prediction
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this prospective, randomized study, the investigators assess the intubation conditions
      during videolaryngoscopy with Glidescope Titanium whether patients receive (curare
      (Atracurium)group) or no (control group) within elective surgery patients with no difficult
      intubation prediction. The IDS score assessed by an anesthesiologist from the
      video-recording is the primary outcome. All general anesthesias are standardized using
      Target Control Infusion of propofol and sufentanil. The investigators also compare IDS
      scores as assessed by intubators, time for tracheal intubation, and laryngeal morbidity in
      both groups.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2015</start_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>IDS score video-assessed as described by Adnet et al. Measurement will be made by 2 experts anesthesiologists for centralized reading</measure>
    <time_frame>Assessment will be done at the end of the inclusions period (9 months)</time_frame>
    <description>Number of IDS scores &lt;2 are compared</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>IDS score assesed by the intubator anesthesiologist</measure>
    <time_frame>3 days post intubation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Tracheal Intubation</condition>
  <arm_group>
    <arm_group_label>Control group (saline isotonic solution)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>saline isotonic solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Curar (Atracurium) group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Curar (Atracurium)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Curare (Atracurium)</intervention_name>
    <description>Curare (Atracurium) versus saline isotonic solution for tracheal intubation</description>
    <arm_group_label>Curar (Atracurium) group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline isotonic solution</intervention_name>
    <arm_group_label>Control group (saline isotonic solution)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective Surgery Adult Patients

          -  no difficult intubation prediction

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Beny CHARBIT</last_name>
    <email>bcharbit@chu-reims.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nicolas ROCHART</last_name>
    <email>nrochart@chu-reims.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chu de Reims</name>
      <address>
        <city>Reims</city>
        <zip>51092</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beny CHARBIT, MD PhD</last_name>
      <email>bcharbit@chu-reims.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <lastchanged_date>June 8, 2016</lastchanged_date>
  <firstreceived_date>March 17, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Trachel intubation</keyword>
  <keyword>IDS score</keyword>
  <keyword>Videoaryngoscopy</keyword>
  <keyword>Glidescope® Titanium®</keyword>
  <keyword>NMBA</keyword>
  <keyword>Curare (Atracurium)</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Atracurium</mesh_term>
    <mesh_term>Curare</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
